Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity
about
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionHemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and miceTunable and label-free virus enrichment for ultrasensitive virus detection using carbon nanotube arraysStructural basis for receptor specificity of influenza B virus hemagglutininStructural and Antigenic Variation among Diverse Clade 2 H5N1 VirusesStructural and genetic basis for development of broadly neutralizing influenza antibodiesUse of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness.Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses.Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease courseNovel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity.Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.Low Virulence and Lack of Airborne Transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in Ferrets.Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective.Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013The pig as a mixing vessel for influenza viruses: Human and veterinary implications.Glycans on influenza hemagglutinin affect receptor binding and immune responseMutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses.Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificityInduction of broadly neutralizing H1N1 influenza antibodies by vaccination.Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential.Influenza A virus transmission: contributing factors and clinical implications.Virulence determinants of pandemic influenza viruses.Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus.Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 virusesVaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A VirusThree mutations switch H7N9 influenza to human-type receptor specificity.DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding.Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles.The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host.Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.H5N1 receptor specificity as a factor in pandemic riskAntigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.
P2860
Q24631774-A676B1E0-9F2F-4A77-9C3C-37A5899FA271Q26700091-06C975E2-6EE0-4A3C-9C2B-282557B45312Q27301043-CD93DF04-718F-4798-A568-FF98A07F2730Q27468585-608CC9D3-8E55-4E36-B982-3FE41AC4F324Q27648813-38EF537C-8E31-4D2D-8C50-45327D8D4291Q27680129-514CA181-8041-4B98-9C92-33295B78C7A1Q27682070-C65EEBE5-4924-470C-94C5-0B85A4BDB731Q30205712-6BE00590-2530-40AE-81E0-C3BADFE4EE2DQ30362721-88095B12-1147-4942-8EE5-4EEB3AB7DA64Q30363631-76066089-9183-41A9-8D15-1189F652F2CDQ30366819-954A5EF9-229D-4BCA-90B9-341122B67FE9Q30371137-9AFC2964-2334-42A1-962E-3BA50FED6941Q30371649-0A59C850-9881-4484-9D1A-66FB9F4C2D4BQ30372360-1CDA25EA-7712-4EB4-AD2C-C83B286B1EE0Q30375847-3267F957-44DE-4F7C-99B2-4ABA709D0382Q30376058-7F0A7322-073B-41AC-82A6-0E7ABCB98951Q30377552-4B6E7B34-F6F1-4C0C-ADF6-2AF41F904AFCQ30378521-F4CFE451-D018-4352-BDE5-29B14C1345D9Q30381577-B90E4E15-6063-491B-8F67-E2FDCA7FB743Q30382671-75535D98-1778-4240-824B-36D97716472FQ30384563-7176A0F8-2CA1-408B-B88E-57666759BC2CQ30386603-5B2FC47E-7550-45B7-9BDC-3739165C0423Q30387829-A0D24811-3DC9-4A6D-BC8D-9A6AE98AC7E2Q30388086-CA9B90CA-9B47-4805-BC92-F6A6AFEAEA44Q30391652-5B1EA5E3-AAB1-4D99-8CD6-0017B15C32C2Q30396667-43436AE7-3381-4F0B-AE1F-5DC8BBAD2753Q30397203-48350670-7E2C-492C-981E-171846283B6EQ30398168-333AE655-66A2-4016-89F6-6FCC4B6D537DQ30399477-E1CFEE5C-6539-4115-A8AA-8DF5161003AAQ30400680-03233AF7-B9B7-4366-BA46-725B5C49B914Q30401849-75593878-8CF8-43F6-89C6-B419A9C52250Q30403091-27E72286-3CDF-40EC-A2BA-CA49E2E0C4D0Q30407081-4F107586-0B35-481C-9117-1156B0BC7A54Q30411149-C1C4C453-26E6-4394-880C-799747853828Q30414700-05DE3AAC-817A-491C-984B-B975A40B39B4Q30418340-7E0CE0F2-B559-41E5-89F4-5AA9F3FE7665Q30418377-2EC167ED-9466-4030-B35A-89998A886245Q30421007-A0DCDB9B-42E7-495C-96D5-335D77404527Q30429803-4CEBC590-9A32-41E4-A57D-08B87AE7C5A8Q30517014-B0649BB6-FA1B-41DD-B3D7-411BCD8CB3D7
P2860
Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Immunization by avian H5 influ ...... d receptor binding specificity
@ast
Immunization by avian H5 influ ...... d receptor binding specificity
@en
Immunization by avian H5 influ ...... d receptor binding specificity
@nl
type
label
Immunization by avian H5 influ ...... d receptor binding specificity
@ast
Immunization by avian H5 influ ...... d receptor binding specificity
@en
Immunization by avian H5 influ ...... d receptor binding specificity
@nl
prefLabel
Immunization by avian H5 influ ...... d receptor binding specificity
@ast
Immunization by avian H5 influ ...... d receptor binding specificity
@en
Immunization by avian H5 influ ...... d receptor binding specificity
@nl
P2093
P2860
P3181
P356
P1433
P1476
Immunization by avian H5 influ ...... d receptor binding specificity
@en
P2093
Chih-Jen Wei
David F Smith
Wing-Pui Kong
P2860
P3181
P356
10.1126/SCIENCE.1135165
P407
P577
2007-08-10T00:00:00Z